Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Peters, Terri
TriKe, NCT05336968: Triamcinolone Ketorolac () Knee Trial	Recruiting	4	150	US	Triamcinolone acetonide-Ketorolac-Ropivacaine	United Health Services Hospitals, Inc.	Osteoarthritis, Knee	11/25	12/25
NCT05307458: Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing	Recruiting	N/A	20	US	Buprenorphine/naloxone	United Health Services Hospitals, Inc., Binghamton University	Opioid Use Disorder, Opioid Withdrawal	06/24	12/24
NCT05878210: Evaluating the SUBLOCADE Treatment Exit Strategy	Active, not recruiting	N/A	25	Canada, US		Indivior Inc.	Opioid Use Disorder	05/25	05/25
NCT05860959: SUBLOCADE Long-term Outcomes	Recruiting	N/A	1200	Europe, Canada, US, RoW		Indivior Inc.	Opioid Use Disorder	08/27	08/27
Hunter, Stanley
TriKe, NCT05336968: Triamcinolone Ketorolac () Knee Trial	Recruiting	4	150	US	Triamcinolone acetonide-Ketorolac-Ropivacaine	United Health Services Hospitals, Inc.	Osteoarthritis, Knee	11/25	12/25